Tag: regulatory inspection

Steps to Prepare for Regulatory Inspections of Ongoing Stability Programs In the fast-evolving pharmaceutical landscape, a robust ongoing stability program is pivotal for ensuring product efficacy and compliance. However, gaps…

Addressing Failures in Ongoing Stability Programs Due to Insufficient Protocols In the pharmaceutical industry, ongoing stability program failures present significant challenges, particularly when driven by inadequate protocols. These failures can…

Aligning Ongoing Stability with ICH and Regional Standards The pharmaceutical industry faces numerous challenges related to compliance with International Council for Harmonisation (ICH) guidelines while managing ongoing stability programs. Recognizing…

Addressing Gaps in Ongoing Stability Programs for Temperature Excursion Impact Assessment In the pharmaceutical manufacturing environment, maintaining the integrity of stability studies is vital to ensure product quality and regulatory…

Addressing Gaps in Ongoing Stability Programs Across Manufacturing Sites Managing ongoing stability programs is crucial for ensuring that pharmaceutical products meet quality standards throughout their shelf life. Companies often grapple…

Effectively Auditing Ongoing Stability Programs to Identify Gaps Pharmaceutical stability programs are essential for ensuring the quality and efficacy of drug products throughout their shelf life. However, ongoing stability program…

Addressing Gaps in Your Ongoing Stability Program for Effective QA Management Pharmaceutical companies are increasingly challenged by the demands of ongoing stability programs. A comprehensive approach to stability testing is…

Detecting Packaging Failures Using Ongoing Stability Data In the pharmaceutical industry, the integrity of packaging is crucial to ensure product efficacy and safety throughout its shelf life. Failures in packaging…

Addressing Ongoing Gaps in Stability Programs for Enhanced Compliance Pharmaceutical professionals often confront challenges with ongoing stability program gaps that can pose significant risks to compliance, product quality, and patient…

Strategies to Mitigate Ongoing Stability Program Gaps in Pharmaceutical Manufacturing Data integrity issues in ongoing stability programs pose significant risks for pharmaceutical manufacturers, particularly given the escalating scrutiny from regulatory…

Identifying and Addressing Gaps in Ongoing Stability Programs for Liquid Pharmaceuticals In the pharmaceutical industry, maintaining the integrity and quality of products over time is a critical concern, especially for…

Guidelines for Addressing Ongoing Stability Program Gaps Pharmaceutical professionals often face challenges in ongoing stability programs that can lead to regulatory non-compliance and compromised product quality. In this article, we…